Results 1 to 10 of about 9,727 (224)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension [PDF]

open access: goldPulmonary Circulation, 2022
Pulmonary veno‐occlusive disease (PVOD) is a progressively fatal disease with no definitive treatment options. PVOD can be a result of genetic mutation but can also be due secondary to exposure to solvents or chemotherapeutic agents.
Sarah Beshay   +3 more
doaj   +4 more sources

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension. [PDF]

open access: gold, 2016
BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare disease with an emerging genetic basis. Heterozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) are the commonest genetic cause of PAH, whereas ...
Charaka Hadinnapola   +325 more
core   +28 more sources

Anti-synthetase syndrome-associated pulmonary veno-occlusive disease [PDF]

open access: goldPulmonary Circulation, 2020
Pulmonary arterial hypertension has been reported with a prevalence of 7.9% in patients with anti-synthetase syndrome; however, anti-synthetase syndrome associated with pulmonary veno-occlusive disease (PVOD) has never before been described in the ...
Dana Kay   +5 more
doaj   +4 more sources

Pulmonary veno‐occlusive disease with vanished pulmonary consolidation [PDF]

open access: yesRespirology Case Reports, 2023
Key message Pulmonary veno‐occlusive disease (PVOD) is an extremely rare cause of pulmonary hypertension. Previously reported computed tomography (CT) findings of PVOD included centrilobular ground‐glass opacities, a mosaic pattern, and septal lines ...
Kei Yamasaki   +6 more
doaj   +2 more sources

Genetic cause of pulmonary veno-occlusive disease [PDF]

open access: yesLung India, 2022
Pulmonary veno-occlusive disease (PVOD) is an important cause of pulmonary arterial hypertension (PAH) and is classified under idiopathic cause of PAH. Over a period of time, PVOD has been studied in detail in the western countries and various diagnostic
Kaustubh Mohite, Anil Kumar Sapare
doaj   +2 more sources

Mitomycin induced pulmonary veno-occlusive disease [PDF]

open access: yesRespiratory Medicine Case Reports, 2021
Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules.Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with ...
Afua Kunadu   +5 more
doaj   +2 more sources

Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease [PDF]

open access: yesPulmonary Circulation, 2022
Pulmonary veno‐occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH) is a rare subtype of pulmonary hypertension with dismal prognosis.
Junichi Nakamura   +12 more
doaj   +2 more sources

Pulmonary hypertension secondary to pulmonary veno occlusive disease: Catastrophe in the catheterization laboratory

open access: diamondAnnals of Pediatric Cardiology, 2020
Anuj Sharma   +4 more
doaj   +3 more sources

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation [PDF]

open access: yesCase Reports in Oncology, 2023
Pulmonary veno-occlusive disease (PVOD) is an extremely rare condition in oncology practice. Although PVOD is clinically similar to pulmonary arterial hypertension, the conditions differ in terms of pathophysiology, management, and prognosis. This report
Takashi Hamada   +14 more
doaj   +2 more sources

Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno‐occlusive disease [PDF]

open access: yesRespirology Case Reports, 2023
We present a 41‐year‐old man with idiopathic interstitial pneumonia and pulmonary hypertension (PH) in the setting of a non‐autoimmune background whose clinical presentation masqueraded pulmonary veno‐occlusive disease (PVOD).
Hiroki Nakayama   +13 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy